Copyright
©The Author(s) 2017.
World J Clin Oncol. Dec 10, 2017; 8(6): 429-436
Published online Dec 10, 2017. doi: 10.5306/wjco.v8.i6.429
Published online Dec 10, 2017. doi: 10.5306/wjco.v8.i6.429
Figure 1 Percent of cases and 5-year relative survival by stage at diagnosis: Liver and intrahepatic bile duct cancer.
Figure 2 Development of hepatocellular carcinoma in non-alcoholic fatty liver disease.
Figure 3 Barcelona clinic liver cancer staging system[36].
HCC: Hepatocellular carcinoma; TACE: Trans-arterial chemoembolization.
- Citation: Said A, Ghufran A. Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma. World J Clin Oncol 2017; 8(6): 429-436
- URL: https://www.wjgnet.com/2218-4333/full/v8/i6/429.htm
- DOI: https://dx.doi.org/10.5306/wjco.v8.i6.429